Detalles de la búsqueda
1.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med;
17(1): 296, 2019 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464635
2.
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
Clin Genitourin Cancer;
22(2): 126-133.e2, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932204
3.
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27.
Clin Genitourin Cancer;
22(3): 102078, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38631104
4.
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.
Ther Adv Urol;
16: 17562872241244574, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38638242
5.
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
Clin Genitourin Cancer;
22(3): 102074, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616147
6.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol;
7(1): 102-111, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481365
7.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol;
75(4): 460-470, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37530662
8.
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
Front Oncol;
11: 682449, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34168997
9.
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7).
Am J Clin Oncol;
44(3): 121-125, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33617179
10.
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study.
Clin Pharmacol Ther;
106(2): 422-431, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739312
11.
The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis.
Crit Rev Oncol Hematol;
131: 83-89, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293710
12.
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.
Cancer Chemother Pharmacol;
57(1): 34-9, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16010592
13.
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.
Front Pharmacol;
7: 331, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27733829
Resultados
1 -
13
de 13
1
Próxima >
>>